TY  - GEN
AU  - Calvaruso,Vincenza
AU  - Mazzarelli,Chiara
AU  - Milazzo,Laura
AU  - Badia,Lorenzo
AU  - Pasulo,Luisa
AU  - Guaraldi,Giovanni
AU  - Lionetti,Raffaella
AU  - Villa,Erica
AU  - Borghi,Vanni
AU  - Carrai,Paola
AU  - Alberti,Alfredo
AU  - Biolato,Marco
AU  - Piai,Guido
AU  - Persico,Marcello
AU  - Santantonio,Teresa
AU  - Felder,Martina
AU  - Angelico,Mario
AU  - Montalbano,Marzia
AU  - Mancusi,Rossella Letizia
AU  - Grieco,Antonio
AU  - Angeli,Elena
AU  - D'Offizi,Gianpiero
AU  - Fagiuoli,Stefano
AU  - Belli,Luca
AU  - Verucchi,Gabriella
AU  - Puoti,Massimo
AU  - Craxì,Antonio
TI  - Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
SN  - 2045-2322
PY  - 2020///0723
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - adverse effects
KW  - Carbamates
KW  - Drug Therapy, Combination
KW  - methods
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Female
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Imidazoles
KW  - Isoquinolines
KW  - therapeutic use
KW  - Italy
KW  - Liver Cirrhosis
KW  - drug therapy
KW  - Liver Function Tests
KW  - Male
KW  - Middle Aged
KW  - Pyrrolidines
KW  - Ribavirin
KW  - Sofosbuvir
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Valine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/s41598-018-36734-0
ER  -